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Abstract
Background: The effects of non-sedation on cognitive function in critically ill patients on mechanical ventilation are not
yet certain. This trial is a substudy of the NONSEDA trial where critically ill patients are randomized to non-sedation or to
sedation with a daily wake-up attempt during mechanical ventilation in the intensive care unit (ICU).
The aim of this substudy is to assess the effects of non-sedation versus sedation with a daily wake-up attempt on
long-term cognitive function.
Methods: This is an investigator-initiated, randomized, clinical, parallel-group, superiority trial, including 200 patients.
Inclusion criteria will be adult patients who are intubated and on mechanical ventilation with an expected duration of
more than 24 hours. Exclusion criteria will be patients who are comatose at admission and patients with conditions
requiring therapeutic coma (i.e., severe head trauma, status epilepticus, patients treated with therapeutic hypothermia and
patients with severe hypoxia).
The experimental intervention will be non-sedation supplemented with pain management during mechanical ventilation.
The control intervention will be sedation with a daily wake-up attempt.
The primary outcome will be cognitive function 3 months after discharge from intensive care.
The secondary outcomes will be the results of seven specific cognitive tests, performed 3 months after discharge from
intensive care, and the association between hypoactive and agitated delirium during ICU admission and long-term
cognitive function.
Discussion: If non-sedation can improve long-term cognitive function, it could be an approach worth considering for a
larger group of critically ill patients.
Trial registration: The study has been approved by the relevant scientific ethics committee and is registered at
ClinicalTrials.gov (ID: NCT02035436, registered on 10 January 2014).
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Background
This current trial is a substudy of the multinational
NONSEDA trial (ClinicalTrials identifier: NCT01967680)
[1]. The aim of the NONSEDA trial is to assess the
benefits and harms of non-sedation versus sedation
with a daily wake-up attempt in critically ill patients
in the intensive care unit (ICU). Seven hundred pa-
tients will be randomized to non-sedation versus sed-
ation with a daily wake-up attempt.
This substudy concerns long-term cognitive function
and will be based on 200 of the 700 NONSEDA trial
patients. The 200 patients will be included and treated
in the ICU at trial site Kolding, Denmark. They will be
followed up by a neuropsychologist 3 months after dis-
charge from the ICU to assess their cognitive function.
Patient population
Approximately 30,000 patients (2–3 % of all hospital
patients) are admitted to ICUs in Denmark every
year. In 2013–2014 the 30-day mortality for ICU pa-
tients was 27.1 % [2]. An intensive care admission
can have substantial consequences for patients and
studies show that ICU survivors have a reduced qual-
ity of life and an increased mortality for several years
after discharge [3].
Current care and treatment
Patients on mechanical ventilation are continuously
sedated as a part of the standard approach. The first
ventilators were rather primitive and highly uncom-
fortable for the patients, making sedation necessary.
As ventilators have become more and more sophisticated,
and now allow a high degree of patient-ventilator inter-
action and relative comfort, lighter levels of sedation
are possible. Numerous trials have documented the
beneficial effects of less sedation, namely shorter dur-
ation of mechanical ventilation, lower morbidity and
shorter length of stay in the ICU and in hospital [4–10].
Critical illness affects both body and mind. Ehlenbach
et al. analyzed 14-year follow-up data from a large co-
hort of older adults, and found that those who experi-
enced acute care hospitalization and critical illness had
a greater likelihood of cognitive decline compared with
those who had no hospitalization [11]. Several studies
document long-term cognitive impairments after, for
example, acute respiratory distress syndrome or sepsis
[12, 13]. The multicenter BRAIN-ICU study investi-
gated long-term cognitive function in 821 patients after
critical illness and found that 40 % of the patients had
significant cognitive impairment at 3 months post ICU
stay and 34 % at 12 months post ICU stay [14].
Delirium is a known risk factor for long-term cognitive
impairment, and a common complication of critical ill-
ness [15–18]. Delirious patients can be either agitated,
hypoactive or a mixture of the two. The type of delir-
ium might affect cognitive function differently. For
example, van den Boogaard found that those with
hypoactive delirium had a higher mortality compared
to agitated delirium, but might have a better long-term
cognitive function [16]. It is difficult, if not impossible
to diagnose delirium in sedated patients and it is, there-
fore, not surprising that our group, in a previous trial,
observed a higher incidence of agitated delirium in
non-sedated patients compared to sedated patients [5].
The patients in this previous trial were not assessed for
long-term cognitive function.
The effect of non-sedation on long-term cognitive
function has not been established, but several studies
indicate that less sedation is not associated with
impaired long-term cognitive function. Jackson et al.
conducted a randomized trial, comparing daily spon-
taneous awakening trials to sedation per usual care
[19]. They did not find adverse cognitive outcomes in
the more awake patient group. Neither a recent meta-
analysis nor the BRAIN-ICU study found that low
sedation levels were associated with a higher inci-
dence of cognitive dysfunction [20].
Methods
Aim and hypotheses
The aim of this randomized clinical trial is to assess the
effects of non-sedation on cognitive function following
ICU discharge.
Our primary hypothesis is that non-sedation com-
pared with sedation and a daily wake-up trial will
lead to a better long-term cognitive outcome.
We also hypothesize that both agitated and hypoac-
tive delirium are negatively correlated with long-term
cognitive function.
Design
The trial is a substudy in the NONSEDA trial [1].
The NONSEDA trial is an investigator-initiated, ran-
domized, clinical, parallel-group, multinational, super-
iority trial designed to include 700 patients from at
least six ICUs in Denmark, Norway and Sweden. This
substudy will be based on 200 of these 700 patients,
namely those who are included at trial site Kolding,
Denmark.
Randomization
Patients will be randomized to one of the two
groups within 24 hours after intubation. If the pa-
tient arrives intubated from another ICU, the patient
will be randomized within the first 24 hours after
arrival. The randomization will be carried out cen-
trally by the Copenhagen Trial Unit according to a
computer-generated allocation sequence with a
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variable block size, kept concealed from investigators
at the clinical sites.
The allocation sequence will be stratified by center,
age (up to 65 years or older) and the presence of
Shock entails a systolic BP below 70 mmHg.
The 200 patients for this substudy will be all the
patients included at trial site Kolding, Denmark. Since
we will stratify for center, we will obtain an equal
distribution of patients.
Blinding
Due to the nature of the trial interventions, it will not
be possible to blind the ICU staff or the participants to
the individual participants’ randomization status. All
other parties in the trial, including the neuropsycholo-
gist who conducts all the follow-up assessments, will
be blinded. The statistical analyses will be conducted
blinded with the two intervention groups coded as,
e.g., A and B.
Inclusion criteria
 Age 18 years or older
 Receiving endotracheal intubation
 Expected time on ventilator longer than 24 hours
 Informed consent obtained
Exclusion criteria
 Severe head trauma where therapeutic coma is
indicated
 Therapeutic hypothermia where therapeutic coma is
indicated
 Status epilepticus where therapeutic coma is
indicated
 Previous participation in this trial (during previous
ICU admission)
 Transferral from another ICU with admission for
more than 48 hours
 Comatose at admission
 Severe hypoxia (partial pressure of oxygen in
arterial blood/fraction of oxygen in inspired air
(PaO2/FiO2) ≤9) where sedation might be
necessary for oxygenation or the need to position
the patient in the prone position
Trial site and personnel
The trial site is the Intensive Care Unit, Lillebaelt
Hospital, Kolding, Denmark; a mixed medical and
surgical ICU with 11 ICU beds and three intermedi-
ate care beds. The unit treated 998 patients in 2014
and 988 patients in 2015. The trial personnel will be
doctors and nurses working in Kolding ICU. The
personnel are already used to working with non-
sedation and handling awake, mechanically ventilated
patients as well as sedated patients with daily wake-
up trials. The trial group will monitor the clinical
work and, if needed, provide supplementary training
in non-sedation and daily wake-up trials, both in the-
ory and by supervised practice.
Interventions
As described in the NONSEDA trial protocol, the
intervention consists of non-sedation supplemented
with pain management versus sedation with a daily
wake-up trial. In this substudy we will investigate
how non-sedation versus sedation with a daily wake-
up trial affects physical function after ICU discharge.
For details about the interventions please see the
NONSEDA trial protocol [1] (Fig. 1).
Outcomes
The primary outcomes will be:
 Cognitive function 3 months after discharge from
ICU, measured as a composite cognitive score. The
score for each patient will be diagnosed by the
neuropsychologist
 Number of patients with cognitive impairment in
the two groups, as defined by Girard et al. [15]:
◦ mild to moderate cognitive impairment if
participants had either two cognitive test scores at
1.5 standard deviations (SD) below the mean or
one cognitive test score at 2 SD below the mean
◦ severe cognitive impairment if participants had
three or more cognitive test scores at 1.5 SD
below the mean or two or more cognitive test
scores at 2 SD below the mean
The secondary outcomes will be:
Cognitive function, assessed by following neuro-
psychological tests:
 Span of numbers
 Coding test
 Trailmaking A + B
 Rey auditory verbal learning test (immediate, recall)
 Rey-Ostherrieth complex figure test (immediate)
 Rey-Ostherrieth complex figure test (delayed recall,
recognition)
 Word-finding test (S-words and animals)
Effect of delirium during ICU admission:
 Hypoactive delirium, measured as the association
between the occurrence of hypoactive delirium
(Richmond Agitation-Sedation Scale (RASS) ≤0,
Confusion Assessment Method for the Intensive
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Care Unit (CAM-ICU)-positive) and cognitive
function after 3 months
 Agitated delirium, measured as the association
between the occurrence of agitated delirium
(RASS ≥ +2, CAM-ICU-positive) and cognitive
function after 3 months
Safety
There is no known risk associated with participation
in the substudy. As a part of the NONSEDA trial
protocol we register accidental extubation requiring
re-intubation within an hour, and accidental removal
of a central venous line requiring reinsertion within
4 hours, as serious adverse events and an interim
analysis will be performed.
Inclusion of patients
Patients can be admitted to the ICU either from other
wards at the same hospital or transferred from an ICU
in another hospital. If they are admitted from within
the same hospital, they are either not intubated or have
been intubated within a very short time: for example,
during pre-hospital care. Patients will be included in
the study within 24 hours from intubation.
A few patients will be transferred from an ICU in an-
other hospital, and they will very often be intubated. They
can be included in the trial if the stay in the other ICU was
shorter than 48 hours. In the time leading up to inclusion
and randomization, it will vary as to whether patients are
sedated or not, depending on the particular clinician on
duty and traditions at the particular hospital.
Ethics, consent and permissions
The protocol has been approved by the Regional Scientific
Ethical Committees for Southern Denmark (ID: S-
20130025). We will obtain informed consent from the pa-
tients who are sufficiently awake; otherwise the informed
consent will be obtained from the closest relative and the
patient’s general practitioner, or alternatively the Medical
Health Office. The trial is registered at ClinicalTrials.gov,
ID: NCT02035436 (registration date 10 January 2014).
Please see supplement material for SPIRIT-checklist
(Additional file 1) and original consent forms (in Danish,
Additional file 2).
When patients are contacted the first time concern-
ing participation in the study, they will be in the ICU.
Verbal and written information will be given by the
trial coordinator (HKN) or the study nurse. Patients are
informed about the rights to assistance and the possi-
bility of reflection time. Patients will be considered
competent if they are awake and not delirious (CAM-
ICU-negative). The competent patients will give con-
sent after a period of reflection time of up to several
hours. If patients are not awake and not competent
because of their illness, surrogate consent will be ob-
tained from a close relative and the patient’s private
Fig. 1 SPIRIT time schedule. Time schedule of enrollment, intervention, and follow-up assessment
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practitioner, or alternatively the Medical Health Office.
The consent of a relative relies on the patient’s
presumed attitude to participation in clinical trials. The
connection between the relative and the patient will
appear in the surrogate consent form. Like the patient,
the relative will also be given time of up to several
hours to make the decision.
If, for any reason, a patient or their relative no longer
wishes to participate in the trial, they will be asked
for permission to use the previously obtained data in
order to obtain data from electronic patient files for
the rest of the trial period, and to invite the patient
to the 3-month follow-up.
Data management
An electronic Case Record Form (eCRF) for the
NONSEDA trial in OpenClinica has been developed
in cooperation between the coordinating investigator
and a data manager at the Copenhagen Trial Unit.
Daily access to the eCRF will be possible around the
clock whereby data can be continuously entered for
all the randomized patients.
The coordinating investigator will monitor the data
input and will contact the primary investigator if data
are missing on one or more randomized patients, in
order to correct or complement inputs to optimize
data quality.
Data collection
All patient data during admission originate from medical
records included in the Critical Information System
(CIS) or other electronic patient files.
Before contacting any patient after discharge, we will
check with national central person registrations to assure
that the patient is not deceased. The process for establish-
ing the follow-up will be as follows: approximately 14 days
prior to the 3-month follow-up we will send a letter to the
participant with an invitation to participate. If the patient
does not respond, we will send a new letter repeating the
invitation. If there is still no response, we will telephone the
patient, repeating the invitation to participate in the follow-
up and clarify any potential misunderstandings concerning
transportation or the like. If the patient declines to come to
the hospital, we will offer to come to the patient’s home
and do the follow-up there.
The neuropsychological assessment will take place
in a quiet room, away from busy wards and free from
disturbances. Drinks and snacks will be provided as
well as time for resting, if needed.
Power estimation
Estimation of power for the primary outcome: 200
patients will be included, and the estimated 90-day
mortality for this group of patients is 40 %, leaving
an estimated 120 patients alive 3 months after dis-
charge from the ICU. We assume a participation in
the follow-up assessment at 75 %, thus leaving 90 pa-
tients to complete the interview, 45 in each group.
With 45 patients in each group, and aiming at the
difference in composite score means being statistically
significant at a 5 % level, the difference in composite
score means should be at least 0.41 times the stand-
ard deviation of the composite score. Then, using a
simple normal test for comparison of two independ-
ent means, a 5 % significance in difference implies:
Δ ¼ 1:96 
ﬃﬃﬃﬃ
V
p

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
45þ 45=45  45
p
¼ 0:41 
ﬃﬃﬃﬃ
V
p
;
where Δ denotes the difference in composite score, V de-
notes the variance for the composite score, which is as-
sumed to be equal in the two groups, and N = 45, the
sample size per group denotes the sample size per group.
Statistical analysis plan
All continuous normally distributed outcome data will
be described by mean, mean difference, standard devi-
ation (SD) and range. Following Rasmussen et al.
standard normal tests will be used to analyze differ-
ences in composite scores between the two groups
[21]. However, multiple regression will be added to
handle repeated measurements and to account for
differences in composition of the two groups due to
the absence of matching. Analyses will be performed
as intention-to-treat.
All patients are followed up for at least 3 months
after discharge via the electronic eCRF, Social Security
Register and the National Patient Register. Missing
data will be handled in accordance with multiple
imputation procedures if missing data are greater
than 5 % and Little’s test is statistically significant
[22]. The imputation result will be considered the pri-
mary overall result but per-protocol analyses will also
be presented. Extreme outliers will be identified and,
if necessary, excluded.
All raw p values and confidence intervals of all out-
come comparisons between the two groups will be
presented. A p value <0.05 will be considered statisti-
cally significant in all analyses.
Statistical analysis of the data will be done using
STATA 14 (Table 1).
Discussion
The purpose of this randomized controlled trial, a
substudy of the NONSEDA trial, is to investigate the
effect of non-sedation during mechanical ventilation
on cognitive function after discharge from the ICU. It
is the first trial to our knowledge to investigate this,
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since the tradition and current standard management
involves a higher degree of sedation.
We have designed this trial to be as realistic and
generalizable as possible. The inclusion criteria are
broad, the exclusion criteria are few and specific, the
setting is an ordinary mixed ICU in a non-university
hospital, patients are tended by multiple caregivers
and the protocol for both the intervention and the
control group is simple and relatively easy to follow
in everyday care. This increases the generalizability
and external validity of the trial.
We have chosen a very thorough testing of cognitive
function. The same experienced neuropsychologist will
test all patients to exclude interrater variability. Rather
than completing questionnaires, patients will attend a
2-hour, semi-structured interview, based on validated
and recognized cognitive tests. To include patients
regardless of their pre-morbid status will cause some
complications with regard to this follow-up assessment.
There will be patients with dementia, stroke, terminal
illness or conditions otherwise compromising them to
an extent where they are simply not able to partici-
pate in the extensive interview. It is very important to
limit the number of patients who not participating in
the follow-up, since these might represent the outliers
of the cognitive spectrum. We will make every effort
to obtain a high participation rate. Rate and reason
for not attending the follow-up will be thoroughly
accounted for.
To blind as to whether patients are sedated or not
is not possible. To minimize bias as much as possible,
all major outcome assessments are performed by the
same neuropsychologist who is blinded to the pa-
tients’ randomization status. It could be argued that
the patients could spoil this blinding by revealing
their randomization, but experience tells us that most
patients are unaware as to which of the two groups
they have been in. Memory can be severely affected
by multiple factors encountered in the ICU: for ex-
ample, critical illness in itself or sedatives. Further-
more, almost every patient will to some extent have
experienced both sedation (at least during intubation)
and non-sedation (at least just prior to extubation)
which can also cause confusion.
Immobility and delirium are considered to be very
high risk factors for cognitive impairment following
critical illness. These are potentially modifiable condi-
tions, and we feel certain that less sedation is a corner-
stone for creating the optimal conditions for this [23].
In this trial we will investigate the importance of de-
lirium on cognitive function. We assess mobilization
and physical function in another separate substudy of
the NONSEDA trial [24].
The goal of modern intensive care is not merely
survival, but survival to a life worth living. In recent
years, an awareness of so called Post-Intensive Care
Syndrome (PICS) has arisen [25–27]. The syndrome
comprises physical, psychological and cognitive seque-
lae after survival of critical illness. Despite awareness
on the syndrome, little is known of about how to
prevent it. Obviously the etiology for PICS must be
multifactorial and highly variable since no two epi-
sodes of critical illness are identical. With the rising
age of the population and treatment modalities
becoming increasingly advanced, a greater number of
fragile patients will survive critical illness. This high-
lights the need for knowledge on how to handle these
patients as gently as possible in an attempt to
Table 1 Cognitive tests used
Test Description Cognitive domain evaluated
Span of numbers [28] Repeating a progressively longer sequence of numbers,
first forwards, then backwards, then naming digits in
numerical order
Attention/concentration
Coding test [28] Translating numbers into figures using an answer key Mental pace
Trailmaking A [29] Drawing a line between consecutive numbers during
a timed period
Mental pace
Trailmaking B [29] Drawing a line between alternating numbers and letters
during a timed period
Executive function
Rey auditory verbal learning test
(immediate and recall) [30]
Repeating 15 words 5 times after hearing them aloud,
and then again after 30 min as recalled
Verbal learning/memory
Rey-Ostherrieth complex figure test
(immediate copy) [30]
Copying a drawing of a complicated geometrical figure
while looking at it
Visual construction
Rey-Ostherrieth complex figure test
(30-min delayed recall and recognition) [30]
Drawing the geometrical figure from memory after 3
and 30 min, and recognizing pieces from it from a
catalog
Visual learning/memory
Verbal fluency test (S-words and animals) [31] Naming as many words as possible beginning with S,
and animals during 1 min each
Executive function/mental flexibility
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preserve their premorbid level of health. With this
trial it is our hope to clarify the “sedation pieces in
the PICS puzzle.”
Trial status
The trial is now actively recruiting patients. Inclusion
of the first patient was on 9 January 2014 and inclu-
sion of the last patient will be on 1 January 2017. As
of 1 March 2016 we have included 148 of the 200
patients.
Additional files
Additional file 1: SPIRIT 2013 Checklist: Recommended items to address
in a clinical trial protocol and related documents. (PDF 130 kb)
Additional file 2: Original consent forms, in danish. (PDF 259 kb)
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